黑米糙米皮对大鼠脂代谢的影响及其分子机制研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
高脂血症(Hyperlipidemia,HLP)是因脂肪代谢或运转异常使血浆的一种或多种脂质高于正常的疾病。因其本身及慢性并发症的危害,再加上高额的治疗费用,使其成为全球性关注的热点问题。HLP与基因缺陷、饮食不当、内分泌失调等因素有关,其病因及发病机制目前尚未完全清楚,其中脂质代谢异常被认为是引发HLP的重要发病机制之一,针对脂质代谢异常的调节成为预防与治疗HLP及其慢性并发症的重要环节。
     降血脂西药起效快且疗效肯定,其毒副作用大且价格昂贵;降血脂中药具有多途径、多环节、多靶点,因其毒副作用也无法长期服用;功能性食品兼有中药优点,且长期服用无毒副作用,在预防和治疗代谢性疾病具有独特优势。已有的研究在功能性食品改善HLP患者脂质代谢方面取得一定成果,但对其作用机制缺乏系统、深入的揭示。
     本研究以本课题组选育的高花色苷黑米良种“福紫681”的糙米皮(黑米皮)和红米良种“福红819”的糙米皮(红米皮),以及从多种食用菌中筛选出具有调血脂功效的红菇、灵芝、竹荪等为材料,通过比较这五种农产品对高脂饮食大鼠血脂水平的影响,从中筛选出黑米皮为降血脂疗效最为显著的农产品。接着以黑米皮为材料,观察其对高脂血症模型大鼠脂代谢、氧化应激、脏器组织病变等方面的影响,并进一步从脂质吸收、合成、转化及调控等方面探讨降血脂作用的分子机制,以期为治疗高脂血症脂质代谢紊乱提供科学依据。主要研究结果如下:
     (一)5种农产品对高脂饮食大鼠血脂水平的影响
     通过长期高脂饮食喂养建立HLP大鼠模型,该实验模型动物表现为毛色偏黄、体重增加较快、不好动、血清TC(总胆固醇)和TG(甘油三酯)升高,符合高脂血症的临床特点。应用黑米皮、红米皮、红菇、灵芝、竹荪对HLP大鼠实验8周,以辛伐他汀作为阳性对照药,观察高脂血症大鼠体重、血清TC、TG水平的变化。结果表明:(1)高脂血症大鼠灌胃辛伐他汀、黑米皮、红米皮、红菇、灵芝和竹荪1-7周,大鼠体重增长均呈现逐渐增加趋势,但与模型组相比,其体重增长速度趋缓;在7-8周,只有黑米皮组的大鼠体重下降,而其他各组体重仍然继续增加;8周后,辛伐他汀、黑米皮、红米皮、红菇、灵芝和竹荪组体重增幅分别降低26.26%、33.16%、39.40%、34.97%、32.15%和6.19%。由此说明,上述5种农产品均可以降低食用高脂饲料大鼠的体重,其中黑米皮对控制大鼠体重效果最为显著。(2)辛伐他汀、黑米皮、红菇、灵芝、竹荪均能不同程度降低HLP大鼠血清的TC、TG含量,其中TC分别下降了18.97%、17.82%、35.06%、27.41%、36.78%,TG分别下降52.00%、57.33%、8%、10.06%、54.67%,而红米皮则升高血清的TC和TG含量,其值分别为12.07%、18.67%。以上试验数据表明,黑米皮对大鼠血脂水平的综合调制效果最为显著,因此选择黑米皮进行进一步试验。(二)黑米皮对高脂饮食大鼠脂代谢的影响
     分别以0.09g/mL和0.045g/mL剂量的黑米皮混悬液20mL/kg对HLP模型大鼠实
     验8周,以辛伐他汀作为阳性对照药,观察黑米皮对HLP模型大鼠体重变化、血脂水平、载脂蛋白、氧化应激、FFA(游离脂肪酸)水平及粪便脂质的影响。结果表明:(1)黑米皮给药8周后,大鼠体重增加得到明显的抑制,并且与剂量呈正相关;与模型组相比较,黑米皮高、低剂量组体重增幅分别降低了33.16%和24.00%。(2)高、低剂量的黑米皮均能显著降低大鼠的降低血清TC、TG、AI(动脉硬化指数)、ApoB(载脂蛋白B)水平,上升HDL-C(高密度脂蛋白胆固醇)、ApoAI(载脂蛋白AI)含量,并且与剂量呈正相关。其中TC分别下降了17.82%和19.54%,TG分别下降了57.33%和17.33%,AI值分别降低了39.81%和23.65%,ApoB分别降低30.83%和30.83%,同时HDL-C分别提高了24.24%和3.03%,ApoAI分别升高了73.68%和68.42%。(3)高、低剂量的黑米皮能够明显降低血清MDA(丙二醛)含量,升高SOD(超氧化物歧化酶)、CAT(过氧化氢酶)、GSH-Px(谷光甘肽过氧化物酶)活性;其中MDA含量比模型组分别降低了33.24%和28.92%,与正常组接近;SOD活性比模型组分别上升了28.60%和32.46%,与正常组无明显差异;CAT活性比模型组分别上升了101.16%和97.69%,接近正常组;GSH-Px活性比模型组分别上升了32.46%和28.60%,显著高于正常组。(4)高、低剂量的黑米皮能够明显降低血清FFA、粪便TC,升高粪便TG含量。其中FFA含量略高于正常组,分别比模型组分别降低了31.54%和39.08%,粪便TC分别比模型组降低36.75%和53.23%,TC含量分别比模型组升高20.37%和5.56%。(三)黑米皮对高脂饮食大鼠脏器组织的保护作用
     分别以0.09g/mL和0.045g/mL剂量的黑米皮混悬液20mL/kg对HLP大鼠实验8周,以辛伐他汀作为阳性对照药,观察黑米皮对HLP模型大鼠肝脏形态和重量、脂肪重量、血清肝酶及肝脏、主动脉和心脏脂肪病变的影响。结果表明:(1)黑米皮能够明显降低肝脏和脂肪指数。大鼠试验8周后,与模型组相比较,黑米皮高、低剂量组肝指数分别降低了12.26%和10.63%,脂肪指数分别降低了35.71%和24.29%。(2)显著降低肝脏的TC、TG水平和血清肝酶ALT(丙氨酸氨基转移酶)、AST(天门冬氨酸氨基转移酶)活性。其中黑米皮高、低剂量组大鼠肝脏的TC水平分别降低了59.74%和50.80%;TG水平分别降低了40.63%和20.31%;ALT分别降低了64.50%和35.41%;AST分别降低了41.79%和23.10%。(3)黑米皮能明显改善肝脏和主动脉脂肪性病变,与剂量呈正相关。其中黑米皮高剂量组大鼠的肝和主动脉形态接近正常组,低剂量组的肝脏有轻度脂肪肝、主动脉无脂肪肝,而模型组大鼠肝和主动脉均形成了脂肪肝病症。
     (四)黑米皮改善高脂饮食大鼠脂质代谢作用的分子机制研究
     (1)应用RT-PCR法检测FAS(脂肪酸合成酶)、LCAT(卵磷脂胆固醇脂酰转移酶)、HMG-CoAreductase(羟甲基戊二酰辅酶A还原酶)、CYP7A1(胆固醇7α-羟化酶)及PPARα(过氧化物增殖激活物受体-α)mRNA转录水平,结果表明:黑米皮试验8周后,大鼠肝脏组织的PPARα、CYP7A1mRNA转录水平显著上调,HMG-CoAreductasemRNA转录水平显著下调,LACTmRNA转录水平呈上调的趋势,FASmRNA转录水平呈下调的趋势。(2)应用免疫组化法观察肝脏FAS、LCAT蛋白表达,结果表明:黑米皮试验8周后,大鼠肝脏LACT蛋白翻译水平呈上调趋势,而FAS蛋白翻译水平呈下调趋势。(3)用Westernblot法检测肝脏HMG-CoAreductase、CYP7A1及PPARα蛋白表达,结果表明:黑米皮试验8周后,大鼠肝脏的PPARα、CYP7A1蛋白翻译水平显著上调,HMG-CoAreductase蛋白翻译水平显著下调。提示黑米皮可能通过抑制HMG-CoAreductase的表达,激活PPARα表达,刺激CYP7A1基因启动子,使CYP7A1表达上调,改善脂质代谢异常,进而达到降血脂作用。
The Hyperlipidemia(HLP)is a kind of lipid metabolic disorder. The treatment of the HLP has become a hot global issue because of its harmfuless and chronic complications plus high treatment cost. The HLP is related to gene defect, dietetic irrationality and endocrine dyscrasia, but its cause and pathogenesy remain largely unknown. The abnormal lipid metabolism is considered to be one of the important pathogenesy. The regulation of lipid metabolic abnormalities has become an important link in prevention and treatment of HLP and its chronic complications.
     Hypolipidemic drugs work faster and effective, but they are expensive and have toxicity side effects. Chinese herbal medicines have advantages of multiple channels, links and targets, but it cannot be used for long-term period. Functional foods possess the advantages of Chinese herbal medicine and can be long-term used without toxicity side effects, which has demonstrated the unique advantages in the prevention and treatment of some metabolic disease. Many scholars have made some achievements in improving lipid metabolism of HLP. However, the mechanism remains poorly understood and needs further investigation.
     In this study, we used two rice varieties, the black brown rice variety "Fuzi681" with high anthocyanin and black pericarp, red rice variety "Fuhong819" with red pericarp, and three mushroom varieties, Russula, mythic fungus, and veiled lady to compare the effect of these five agricultural products on blood lipid levels in high-fat diet rats. From these five agricultural products, we had screened one for lowering blood lipid level significantly. Then we observed its effects on lipid metabolism, oxidative stress, organ and vessels lesions in hypolipidemic rats.
     We also investigated the molecular mechanism of hyperlipidemia from the aspects of lipid absorption, synthesis, transformation and regulation. Our research will provide a scientific basis for treatment of metabolic disorders in HLP. The main results are as follows:1Effects of5kinds of agricultural products on the blood lipids level of rats fed with high fat diet
     The model of rat HLP is established by long-term high-fat diet. The animals with yellow fur, weight gained fast, lacking physical activity and increased serum TC and TG are fit for clinical characteristics of HLP. Using simvastatin as positive control, we fed HLP rats with black brown rice pericarp (BBRP), red brown rice pericarp (RBRP), Russula, mythic fungus and veiled lady for8weeks to observe the changes of body weight, the level of serum TC, TG in hyperlipidemic rats.The results show that:(l)From the first to seventh week, the weight gain of HLP rats fed with simvastatin, BBRP, RBRP, Russula, mythic fungus, and veiled lady increased gradually, but the growth rate has slowed down compared with the model group. From seventh to eighth week, only the body weight of rats fed with BBRP decreased, but the body weight of rats fed with others continued to increase. After eight weeks, the body weight gain of rats fed with simvastatin, BBRP, RBRP, Russula, mythic fungus, and veiled lady decreased by26.26%,33.16%,39.40%,34.97%,32.15%and6.19%respectively. This indicates that the mentioned above five agricultural products can reduce the weight of rats fed with high fat diet, and the effect of BBRP on weight control is significant.(2) The level of serum TC and TG in HLP rat was reduced by simvastatin, BBRP, Russula, mythic fungus and veiled lady, with the TC ratio18.97%,17.82%,35.06%,27.41%,36.78%respectively and the TG ratio52%,57.33%,8%,10.06%,54.67%respectively. However, serum TC and TG in HLP rat was increased by RBRP with the ratio12.07%and18.67%respectively. Therefore, we chose BBRP to the following experiments.
     2Effects of BBRP on lipid metabolism in rats fed with high lipid diet
     Using the simvastatin as positive control, we fed the HLP model rats with0.09or0.045g/mL dose of BBRP suspension20mL/kg for8weeks to observe the effect on change of weight, blood lipid, apolipoprotein, oxidative stress, the level of FFA and fecal lipid. The results show that:(1) The body weight gain of rats was significantly inhibited and positively correlated with dosage. The body weight gain was reduced by33.16%and24%in high and low dose group, compared to the model group.(2) The level of serum TC, TG, AI, ApoB was significantly decreased, and the level of HDL-C and ApoAI was increased by high or low dosage of black rice pericarp, which was positively correlated with dosage. The level of TC was decreased by17.82%and19.54%. The level of TG was decreased by57.33%and17.33%. The AI value was decreased by39.81%and23.65%. The level of ApoB was decreased by30.83%and30.83%. The level of HDL-C was increased by24.24%and3.03%. The level of ApoAI was increased by68.42%and73.68%.(3) The level of serum MDA was significantly decreased and the activity of SOD, CAT, GSH-Px was increased by high or low dosage of black rice pericarp. Compared to those in the model group, the level of serum MDA was decreased by33.24%and28.92%. The activity of SOD was increased by28.60%and32.46%, with no significant differences to normal group. Tthe activity of CAT was increased by101.16%and97.69%, closely to normal group. The activity of GSH-Px was increased by32.46%and28.60%, significantly higher than that of normal group.(4) The level of serum FFA and TC in feces was significantly decreased by high or low dose of BBRP, but the level of TG in fecal was increased. The level of FFA was slightly higher than that of normal group, and was decreased by31.54%and39.08%respectively compared to the model group. The level of TC in feces was decreased by36.75%and53.23%respectively, the level of TG in fecal was increased by20.37%and5.56%, compared to the model group.
     3Protective effects of BBRP on the organs and tissues of rats fed with high fat diet
     Using the simvastatin as positive control, we fed the HLP model rats with0.09or0.045g/mL dose of BBRP suspension20mL/kg for8weeks to observe the effects of BBRP on liver morphology and weight, fat weight, liver enzymes, the fatty lesions of liver, aorta and heart. The results show that:(1) The liver and fat index was significantly decreased by BBRP. After the rats were fed with BBRP for8weeks, the liver index were decreased by12.26%or10.63%, and the fat index were decreased by35.71%and24.29%, respectively, in high or low dosage group compared to model group.(2) The levels of liver TC or TG was significantly decreased and the activity of serum ALT or AST was significantly reduced by BBRP. In the liver of rats fed with high or low dosage BBRP, the level of TC was decreased by59.74%and50.80%; TG decreased by40.63%and20.31%; the activity of ALT decreased by64.50%and35.41%; the activity of AST decreased by41.79%and23.10%.(3) The fatty lesions of liver and aorta can be greatly improved by BBRP, which is positively correlated to dosage. The morphology of liver and aortic in high dose group is close to that of normal group. There are mild fatty lesions in the liver with and no fatty lesions in the aorta in low dose group. However, the fatty lesions were formed both in the liver and aorta of rats in model group.
     4Study on the molecular mechanism of improving lipid metabolism of BBRP in rats fed with high fat diet
     In order to test the effects of BBRP on the mRNA level of FAS, LCAT, HMG-CoA reductase, CYP7A1and PPARa in rat liver tissue, we performed reverse transcription-PCR (RT-PCR) analysis to show that the mRNA level of PPARa and CYP7A1were significantly up-regulated and the mRNA level of HMG-CoA reductase was significantly down-regulated, the mRNA level of LACT showed an increased tendency and the mRNA level of FAS showed a decreased tendency after BBRP treatment for8weeks.(2) Our results showed that the protein level of LACT showed an increased tendency and the protein level of FAS showed a decreased tendency after BBRP treatment for8weeks through immunohistochemistry.(3) With the method of Western blot, we detected the expression level of HMG-CoA reductase, CYP7A1and PPAR a protein in rat liver. Our results showed that the protein level of PPARa and CYP7A1were significantly up-regulated and the protein level of HMG-CoA reductase was significantly, down-regulated in rat liver after BBRP treatment. This indicated that the expression of HMG-CoA reductase might be inhibited and the expression of PPARa might be induced by BBRP, which stimulated the CYP7A1promoter causing the up-regulation of CYP7A1. As a result, the lipid metabolism was improved and the blood lipid was reduced.
引文
1. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis[J]. Circulation,2004,109:8-14.
    2. Brousseau ME, Kauffman RD, Herderick EE, et al.LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits[J].Arterioscler Thromb Vase Biol,2000,20(2):450-458.
    3. Crepaldi G, Zambon S, Manzato E.Unsaturated fatty acids in the management of hyperlipidemias[J].World Rev Nutr Diet,1994.(76):38-40
    4. Ebrahim SS, Movahedian AM, Yektaian A. Antihyperlipidemic effect of hydroalcoholic extract and polyphenolic fraction from Dracoce phalum kotschyi Boiss[J].Pharm Aeta Helv,1998,73(3):167-170
    5. Feki M, Souissi M, Mokhtar E, et al.Vitamin E and coronary heart diseases in tunisians[J]. Clin Chem2000,46:1401
    6. Furbee JW Jr, Sawyer JK, Parks JS.Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockoutmice [J].J Biol Chem,2002,277(5):3511-519.
    7. Frankel E.N.,Kanner IGerman J B.et al.Inhibition of oxidation of human low-density Lipoprotein by phenolic substances in red wine [J].Lancet,1993,341:454-457.
    8. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues [J]. J Biol Chem,1957(1):497-509
    9. Garcia Diez F, Garcia Mediavilla V, Bayon JE, et al. Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats [J].J Nutr,1996,126(7):766-1771
    10. Griffin M.E.,Marcucci M.J.,Cline G.W.,et al.Free fatty acids-induced insulin resistance isassociated with activation of protein kinase C theta and alterations in the insulin signaling cascade[J].diabetes,1999:1270-1274
    11. Guan Y, Breyer MD. peroxisome proliferators activated receptors(PPARS):novel therapeutic targets in renal disease. Kidney Int,2001,60:14-30
    12. Hovingh GK, Hutten BA, Holleboom AG, et al.Compromised LCAT function is associated with increased atherosclerosis [J].Circulation,2005,112(6):879-884
    13. Hubacek JA, Bobkova D. Role of cholesterol7alphahydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering. Mol DiagnTher2006,10:93-100
    14. Hwan Hee Jang, Mi Young Park, Heon Woong Kim, et al. Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6Jmice fed a high-fat diet via fatty acid oxidation. Nutrition&Metabolism2012,9:27
    15. Jiao R et al.Hypoeholesterolemic activity of grape seed Proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1[J] J Nutr Biochem,2011,21(11):1134-1139
    16. Karim Bordji,Joel-Panl Grillasca,Jean-Noel Couze,et al,JBiol Chem,2000275:12243
    17. Kim S, Shin HJ, Kim SY, et a.l Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR alpha[J].Mol Cell Endocrino,l2004,220:51-58
    18. Lea A. P., McTavish D., Atorrastatin, et al. A review of its pharmacology and therapeutic potential inthe management of hyperlipidaemias [J]. Drugs,1997,53:828-831
    19. Ling WH,Cheng QX,Ma J,et al.Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits[J].J Nutr,2001,131:1421-1426.
    20. Ling WH,Wang LL,Ma J.Supplementation of the blackrice outer fraction to rabbits decrease atherosclerotic plaque formation and increases antioxidant status[J].J Nutr,2002,132:20-26
    21. Mann J.Dietary carbohydrate:relationship to cardiovascular disease and disorders of carbollydrate metabolism [J].Eur.J Clin.Nult.2007,61:5100-5111
    22. Mark Gurmell,John MW,Mauar Agostini,et al.JBiol Chem,2000,275:5754
    23. MURATA K,KAMEI T,TORIUMI Y,et al..Effect of processed rice with brown rice extracts onserum cholesterol level[J].Clinical and Experimental Pharmacology and Physiology,2007,34:87-89.
    24. Morimitsu Y,KubotaK,TashiroT.Inhibitory effect of anthocyanins and colored rice on diabetic cataract formation in the rat lenses [J].International Congress Series,2002,1245,503-508
    25. Rashad M.M.&Moharib S.A, Effect of type and level of dietary fibre supplements in rats[J].Grasas y Aceites,2003,54(3):277-284
    26. Roncari D A K. Abnormalities of adipose cells in massive obesity [J]. Int J Obes,1990,14(S3):187-192
    27. SAKAMOTO S,HAYASHI T,HAYASHI K,et al.Pre-germinated brown rice could enhance maternal mental health and immunity during lactation[J].European Journal of Nutrition,2007,46:391-396.
    28. Semenknvich C F. Regulation of fatty acid synthase(FAS)[J].Progress in Lipid Research,1997,36:43-63.
    29. SHAMLIYAN T A,JACOBS D J,RAATZ S K,et al.Are your patients with risk of CVD getting the viscous soluble fiber they need[J].Family Practice,2006,55(9):761-769
    30. Shin AH, Oh CJ, Park JW. Glycation—induced inactivation of antioxidant enzymes and modulation of cellular redox status in lens cells. Arch Pharm Res,2006,29:577-581
    31. Spady DK, Cuthbert JA, Willard MN, et al. Adenovirus-mediated transfer of a gene encoding cholesterol7a-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest,1995,96:700
    32. Stuart S, Andrzej W, Anil K J. Structural and functional organization of the animal fatty acid synthase [J]. Prog Lipid Res,2003,40:289-317.
    33. Sung Jip Kim, Hai Dan YUAN, Sung Hyun CHUNG. Ginsenoside Rgl Suppresses Hepatic Glucose Production via AMP-Activated Protein Kinase in HepG2Cells [J]. Biological&pharmaceutical bulletin.2010,33(2):325
    34. Tebib,K.Besancon,P.Rouanet,J.M. Dietary grape seed tannins affect lipoproteins, Lipoprotein lipases and tissue lipids in rats fed hypercholesterolemic diets [J] J Nutr,1994,124:2451-2457.
    35. Uehleke B.,Ortiz M.and Stange R.Cholesterol reduction using Psyllium husks-do Gastrointestinal adverse effects limit comPlianee results of a specific observational study-Phytomedicine [J],2008,15(3):153-159
    36. Wong J.M.,de Souza R,Kendall C.W.,Emam A.and Jenkins D.J.Colonic health: Fermentation and short chain fatty acids [J] J Clin.Gastroenterol.200640:235-243.
    37. Yuanyuan Zuo,a Cheng Peng,a Yintong Liang,, et al. Black rice extract extends the lifespan of fruit flies. Food Funct.,2012,3,1271-1279
    38. Zhang Mingwei.Summary of the nutritional composition and utilization of specialty black cereal and oil crops[J].Asian Food Product Development.Science Press,New York,1998,6-12;
    39. Zhang Mingwei.Nutritional evaluation of some black cereal and oil food resources[J].Journal of South China Normal University(Natural Science)1999,(4):68-74
    40. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification [J].Curr Opin Lipidol,2007,18(1):41-46
    41.陈继承.醋粉中降血脂成分筛选及其对脂质代谢的调控[D].2011,浙江大学博士论文,11-12.
    42.陈起萱,凌文华,梅节.等.黑米和红米抗动脉粥样硬化和抗氧化作用初步研究[J].营养学报,2001,23(3),246-249
    43.陈婷,彭春秀,龚加顺,等.普洱茶茶褐素对高脂血症大鼠血脂代谢的影响.中国食品学报.2011,11(1):20-27
    44.陈伟强,罗少洪,李红枝,等.灵芝多糖对高脂血症大鼠血脂及脂质过氧化的影响[J].中国中药杂志,2005,30(17):1358-1360.
    45.陈玉霞,郭长江.茶多酚降血脂作用及其机制研究进展[J].中国食物与营养,2006,4:47-49
    46.迟晓君.朱靖博.李梅松.等.丹酚酸B调节胆固醇代谢的研究[J].安徽农业科学,2011,39(8):4742-4746
    47.凤志慧,程时.氧化型胆固醇与动脉粥样硬化的关系.生理科学进展,1999,30(l):23
    48.高明菊,赵爱,马妮,等.三七总皂苷软胶囊辅助降大鼠血脂的实验研究[J].华西药学杂志,2012,27(2):146-147
    49.高达,王依宁,许宏伟,等.卵磷脂胆固醇酰基转移酶基因多态性与家族聚集性脑出血及血脂的相关性[J].中国动脉硬化杂志,2010,18(3):227-231
    50.高丽芳,曹丽歌,田蜜,等.脂肪酸合成酶抑制剂胖大海提取物对营养性肥胖大鼠的减肥作用[J].首都医科大学学报,2011,32(4):541-543
    51.国家中药管理局.《中华本草》第一册[M].上海科学技术出版社.1999:511-603
    52.郭庆妍,杨文强,于瑞叶.高脂血症与肝功能损伤的关系研究[J].中华现代内科杂志.2006,3(9):1031-1032.
    53.顾德法.紫黑糯米皮层对促进小鼠骨髓机细胞分化和脾淋巴细胞胞增殖的影响[J].中国水稻科学,1996,10(4):250-252
    54.韩增虎.谷胱甘肽过氧化氢酶的功能及在运动人体科学中的研究进展.体育世界,2012,3:108-109
    55.郝孟芳.中药治疗高脂血症的临床体会[J].实用中西医结合杂志,1995,8(3):149
    56.胡叶碧.改性玉米皮膳食纤维的酶法制备及其降血脂机理研究[D].江南大学博士论文,2008
    57.胡巢凤.中药GST防治脂肪肝的作用和机制研究[D].暨南大学博士论文,2009:83
    58.侯方丽,张瑞芬,张名位,等.黑米花色苷对四氯化碳亚急性肝损伤的保护作用及其机制[J].营养学报,2009,31(3):254-259.
    59.胡艳,郭红辉,王庆,等.黑米花色苷提取物对高脂膳食诱导大鼠肥胖形成的影响[J].食品科学,2008,29(2):376-379
    60.黄翠莉,吴苏喜,刘瑞兴等.油茶籽油对大鼠降血脂和预防脂肪肝的影响[J].食品科学.2011,32(13):332-335
    61.黄卫祖,景爱萍.灵芝调脂灵口服液治疗高脂血症疗效观察[J].中国医药,2007,2(4):211-212
    62.黄永艳.化痰活血方对高脂血症大鼠调脂作用的机制研究[D].湖北中医学院博士论文,2006:10
    63.金丽琴,刘明达,吕建新,等.黑米花色素苷对大鼠组织器官功能的影响[J].中国生化药物杂志,2012,33(1):16-19
    64.金瑾.黄连解毒汤化学成分分析及其抗高脂血症作用的研究[D].吉林大学博士论文,2008:26
    65.景怡,景荣琴,任远,等.玉米须总黄酮对高脂血症大鼠血脂及血液流变学指标的影响[J].中国新药杂志,2010,19(9):797-800
    66.蒋敏,许玉芳,苗竹林.大豆异黄酮对围绝经期妇女血脂水平的影响[J].中国实用医药,2008,3(17):49-51
    67.姜伟伟.黑米皮提取物对PC-3细胞增殖的影响及机制研究[D].中南大学硕士论文,2010:1-2
    68.江正菊,单琳琳,胡霞敏,桑叶总黄酮对大鼠血脂早期干预的实验研究[J].时珍国医国药,2011,22(3):595-596
    69.雷晓林,刘伟,王瑞丞.灵芝三七降脂片对高脂血症大鼠降血脂作用的实验研究[J].中国实用医药,2009,4(16):24-25
    70.李红,刘树兴,张东升.黑色食品保健功能的探讨[J],农产品加工学,2007,(9):72-76
    71.李红艳,李静,宋腾耀,等.超重及肥胖患者血浆游离脂肪酸浓度、血糖、血脂水平及其关系分析[J].陕西医学杂志,2007(8):993-995
    72.李晶晶.黑米抗氧化作用的基因型差异及抑制动物肿瘤研究[D].福建农林大学硕士论文,2010:1-2
    73.李君贵,王爱萍.制首乌茶对高脂血症70例降脂疗效观察[J].中国全科医学,2001,4(8):627
    74.李义龙,张岩.游离脂肪酸在糖尿病中临床意义及研究进展[J].国际检验医学杂志,2008,29(10):954-957
    75.李森柱,谢意珍,周静文等.灵芝孢子油主要活性成分及降血脂功能的研究[J].中国食用菌,2005,25(3):40-43)
    76.梁婧婧.甘薯水溶性糖蛋白的提取纯化及降血脂机理的研究[D].沈阳农业大学博士论文,2009:20-21
    77.刘北林,董继生,倪小虎,等.山楂黄酮提取及降血脂研究[J].食品科学,2007,28(5):324-327
    78.刘畅,柴逸峰,刘峰群.中药有效成分降血脂作用和机制研究进展[J].药学实践杂志,2010,28(3):167-170
    79.刘辉.芹菜籽油的提取纯化及降血脂功能研究[D].沈阳农业大学博士论文,2009:1-2
    80.刘静娜.壳聚糖降脂作用机理研究[D].江南大学博士论文,2008:82-83.
    81.刘明达,钱松,金丽琴.黑米花色素苷对大鼠血液生化指标和巨噬细胞功能影响的研究[J].营养学报.2010,32(1):68-71
    82.罗建学,李春风,初晓辉,等.脂肪酸合成酶基因的研究进展[J].中国畜牧兽医,2011,38(6):118-123
    83.马静,夏敏,凌文华,等.黑米皮对ApoE基因缺陷小鼠动脉粥样硬化斑块形成及血脂的影响[J],营养学报,2003,25(1),37-41
    84.马正伟,张喜忠.复合膳食纤维对大鼠脂代谢的长期作用及其机制[J].中国临床康复,2004,8(9):1677-1679.
    85.麦紫欣,关东华,林敏霞等.膳食纤维降血脂作用及其机制的研究进展[J].广东微量元素科学,2011,18(1):11-16
    86.屈岭,王祥生,曹爱国.灵芝健肾胶囊对糖尿病肾病血脂和血流动力学的影响[J].甘肃中医,2011,24(1):28-30
    87.束秋红,张戈.游离脂肪酸与冠状动脉粥样硬化性心脏病相关性的研究进展.医学综述,2009,l5(20):3110-3112
    88.孙玲,张名位,池建伟,等.黑米的抗氧化性及其与黄酮和种皮色素的关系[J].营养学报,2000,22(3):246-249.
    89.苏越.糙米组织结构及功能特性[J].农业科技与装备,2010,(5):20-22
    90.孙可.灵芝多糖抗高血脂症作用研究[D].吉林大学硕士论文,2008:1-2
    91.孙瑞红,李琨,滕文丽,等.大豆异黄酮对高脂大鼠血脂的影响[J].中医药学报,2012,40(6):50-53
    92.卫生部心血管病防治研究中心.中国心血管病报告[M].中国大百科全书出版社,2010:1-2
    93.王彩霞.有色米的品质特性与种皮颜色性状的分子遗传学研究[D].浙江大学博士论文,2007
    94.王庆,韩平华,张名位,等.膳食补充黑米对冠心病患者血浆中氧化应激、炎症和脂质水平的影响[J].中山大学学报:医学科学版,2007,28(3):301-305.
    95.王巍.中国传统调脂药物研究的现状和前景[J].中西医结合杂志,1994,14(l0):636
    96.王琳琳,凌文华,马静,等.黑米皮对高脂诱导的家兔动脉粥样硬化形成的影响[J].营养学报,2002,24(4),372-376
    97.王丽华,叶小英,李杰勤等.黑米、红米的营养保健功效及其色素遗传机制的研究进展[J].种子,2006,25(5):50-54
    98.王洋,贾梦,蔡莉,等.不同剂量大豆异黄酮降血脂作用比较[J].中国食物与营养,2012,18(8):62-64
    99.魏毅.红米糙米中含晒、锌、锗等矿质营养元素的研究[D].四川农业大学硕士论文,2010
    100.吴锋,孟国梁,杨丽云,等.灵芝多糖预防大鼠动脉粥样硬化的实验研究[J].南通大学学报:医学版,2008,28(4):251-252
    101.吴宏.调脂饮治疗高脂血症50例临床观察[J].湖南中医杂志,2001,17(4):13
    102.小竹英俊,等.脂质代谢.日本医学介绍,2004,25(11):503-50
    103.肖荣,张喜忠,李秀花.食物中可溶性纤维对大鼠脂质水平的影响[J].中国公共卫生学报,1995,14(1):23-26
    104.徐飞.紫黑米提高贫血大鼠血红蛋白作用的研究[J].营养学报,1989,11(2):120-125;
    105.徐先祥,夏伦祝.高家荣.中药皂昔类物质抗氧化作用研究进展[J].中国中医药科技叨,2001,11(2):126
    106.颜新春,汪以真,许梓荣.动物脂肪酸合成酶(FAS)基因表达的调控[J].动物营养学报,2002,14(2):1-4.
    107.杨华,张知贵,李小慧.山楂叶总黄酮对高脂血症大鼠血脂和血液流变性的影响[J].中国实验方剂学杂志,2012,18(12):257-259
    108.应秋霞,张片红.高脂血症合并高尿酸血症的膳食干预[J].浙江预防医学,2010,22(6):84-85.
    109.叶新福.不同基因型稻米营养保健品质及其利用技术研究[D].福建农林大学硕士论文,2009
    110.余小平,夏效东,夏敏,等.黑米花色苷对动脉硬化斑块稳定性影响[J].中国公共卫生,2006,22(2):155-156
    111.于斌,余小平,易龙,等.黑米花青素对HER-2/neu高表达人乳腺癌细胞株MDA-MB-453移植瘤血管生成的影响[J].第三军医大学学报,2009,31(22):2206-2209
    112.曾昭纬.黑稻的营养药用价值与发展应用前景[J].技术开发与引进,1998,1(2):35
    113.张霖.虎杖苷对非酒精性脂肪肝保护作用及机制研究[D].南方医科大学博士论文,2010:98
    114.张名位,郭宝江,池建伟,等.黑米皮提取物的体外抗氧化作用与成分分析[J].中国粮油学报,2005,20(6),49-54
    115.张名位编著.特种稻米及其加工技术[M].北京:中国轻工业出版社,2000,34-89
    116.张思明,全贞玉,韩春姬.血浆维生素E水平与血脂及血压水平的相关性.延边大学医学学报,2011,34(1):46-48
    117.张守文.糙米的营养保健功能[J].粮食与饲料工业,2003,(12):38-41
    118.张文宝.膳食纤维的生理功能及应用[J].农产品加工学刊,2009(9):94-96.
    119.张喜忠,杨燕,马正伟,等.重组膳食纤维对大鼠脂代谢及消化道结构的影响[J].营养学报,1999,21(3):293-298
    120.张英杰,李宗波,刘月琴.不同能量水平日粮对绵羊脂肪酸合成酶(FAS)基因表达的影响[J].中国草食动物,2010(全国养羊生产与学术研讨会议论文集):281-285.
    121.赵则胜.上农香糯,红香玉,上农黑糯,乌贡1号,巨胚稻6601与上农绿米[J].作物研究(国际水稻年专刊),2004,(4):281
    122.赵则胜,沈明泉.天然食用色素“22黑米素”的评价与用途[J].上海农学院学报,1996,14(4):255-2574
    123.周玖瑶,廖惠芳,等.灵芝生酿液降血脂作用研究[J].广东中医药大学学报,2003,20(2):150-152.
    124.赵铁建,钟振国,方卓,等.白花丹水煎液对四氯化碳慢性肝损伤小鼠肝组织脂质过氧化的影响[J].广西医科大学学报.2006,23(5):725-726.
    125.郑金贵.农产品的品质营养与保健[J].福建农业科技,1998,(增刊):11-15
    126.郑楚,杨冬业,徐勤,等.三七花总皂苷对动脉粥样硬化模型大鼠血脂及血液流变学影响[J].中国实验方剂学杂志,2010,16(12):162-164
    127.钟礼云,林文庭.膳食纤维降血脂作用及其机制的研究概况[J].海峡预防医学杂志,2008(14):26-28
    128.朱丽颖,宁光,维生素D与2型糖尿病研究进展[J].中国实用内科杂志,2012,32(8):635-637